Ergoteles’s Omnicell OMCL Stock Holding History

Ergoteles’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,479	Closed	-$321K	–	1373
2023 Q1	$321K	Buy	+5,479	New	+$302K	0.01%	873
2022 Q4	–	Sell	-16,730	Closed	-$1.46M	–	1759
2022 Q3	$1.46M	Sell	16,730 -1,499	-8%	-$157K	0.05%	359
2022 Q2	$2.07M	Buy	+18,229	New	+$2.09M	0.06%	311
2021 Q4	–	Sell	-1,400	Closed	-$208K	–	1492
2021 Q3	$208K	Sell	1,400 -7,205	-84%	-$1.1M	0.01%	970
2021 Q2	$1.3M	Buy	8,605 +1,305	+18%	+$182K	0.03%	443
2021 Q1	$948K	Buy	+7,300	New	+$936K	0.03%	383
2020 Q4	–	Sell	-3,600	Closed	-$269K	–	846
2020 Q3	$269K	Buy	+3,600	New	+$250K	0.04%	383

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Ergoteles's OMCL Position: Q2 2023 in Review

Ergoteles sold out of Omnicell (OMCL) in Q2 2023, closing a stake of 5,479 shares — an estimated $321K sold.

Ergoteles first reported a position in OMCL in Q3 2020 and held it in 7 quarters. The position peaked at $2.07M in Q2 2022. 313 funds tracked by Wall St. Rank hold OMCL as of Q2 2023.

Ergoteles reported no remaining Omnicell position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 5,479 Omnicell shares in Q2 2023, an estimated $321K.
Ergoteles first reported a position in Omnicell in Q3 2020 and held it in 7 quarters.
Ergoteles's Omnicell position peaked at $2.07M in Q2 2022.
313 funds tracked by Wall St. Rank held Omnicell as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.